health_and_safetyGLP-1 Q&A

GLP-1 and Pregnancy

Every GLP-1 label says the same thing: not recommended in pregnancy, with a defined washout period before conception. Here's what the data actually supports, and what to do if a pregnancy is unplanned.

The short answer

GLP-1 medications — Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda — are not recommended during pregnancy. The FDA labels direct prescribers to discontinue the drug when used for weight management upon recognition of pregnancy. Because semaglutide and tirzepatide have long half-lives, the labels recommend stopping at least 2 months before trying to conceive. Use during breastfeeding is also not recommended; data are limited and the drugs may pass into milk.

What the research says

There are no adequate, well-controlled studies of GLP-1 receptor agonists in pregnant humans. Everything in the labels comes from animal reproductive studies and a small body of accidental exposure data.

Animal studies are the load-bearing evidence. The Wegovy label notes that in rats and rabbits, semaglutide at clinically relevant exposures caused embryofetal toxicity, structural abnormalities, and reduced fetal weight. Similar embryofetal findings were reported for tirzepatide and liraglutide. Whether those findings translate cleanly to humans is unknown, but the consistency of the signal across species is why no GLP-1 has a pregnancy use indication.

The half-life is the reason for the washout. Semaglutide has a half-life of approximately one week, which means it takes roughly five to six weeks for it to fully clear and a meaningful additional buffer to ensure no residual exposure during organogenesis. The FDA label specifies discontinuing at least 2 months before a planned pregnancy. Tirzepatide has a similarly long half-life and the same washout recommendation.

Real-world exposure data are accumulating slowly. Pregnancy registries (the Wegovy registry is one example) collect outcomes from accidental exposures. So far, no specific malformation pattern has emerged in humans, but the sample sizes remain too small to rule out a small increase in risk. That is the honest framing.

There is also a contraception wrinkle specific to tirzepatide. The Zepbound and Mounjaro labels note that oral hormonal contraceptives may be less effective for 4 weeks after starting the drug and 4 weeks after each dose escalation because of delayed gastric emptying. Patients on oral birth control are typically advised to switch to a non-oral method or add a barrier method during those windows.

What this means for you

If you are currently on a GLP-1 and might become pregnant, talk to your provider before you try to conceive — not after. The 2-month washout means planning matters. If you stop today, you are generally clear to try at week 8 or 9 with semaglutide or tirzepatide.

If you discover you are pregnant while on a GLP-1, do not panic, but do call your provider promptly. The next step is almost always to stop the medication. Your provider will want to discuss the timing of exposure relative to conception, your overall risk picture, and any follow-up that makes sense (such as a detailed anatomy scan later in pregnancy).

If you are breastfeeding, GLP-1 use is not recommended. The injectable forms do not have human milk data; the oral form (Rybelsus) contains an absorption enhancer that has been detected in milk. The default conservative position is to wait until you are done breastfeeding before restarting therapy, but this is a discussion with your obstetric and primary care team — not a unilateral decision.

Key takeaways

calendar_month

Plan 2 months ahead

FDA labels recommend stopping semaglutide or tirzepatide at least 2 months before trying to conceive, because of their long half-lives.

medical_services

Tell your prescriber promptly

An unplanned pregnancy on a GLP-1 is not an emergency, but the medication should be stopped and your obstetric team should know.

info

Watch oral birth control on tirzepatide

Oral contraceptives may be less effective for 4 weeks after starting Zepbound or Mounjaro and 4 weeks after each dose escalation. Consider a backup method.

Common questions

Common Concerns

How long should I wait after stopping semaglutide before trying to conceive?expand_more

The Wegovy label specifies discontinuing at least 2 months before a planned pregnancy, because semaglutide's half-life is about one week and it takes roughly 5-6 weeks to fully clear, plus a safety buffer. The same 2-month guidance applies to tirzepatide.

I'm already pregnant and on a GLP-1 — what now?expand_more

Call your prescriber and your obstetric provider promptly. The medication is typically stopped immediately. Outcomes data from accidental exposures so far have not shown a specific malformation pattern, but a detailed anatomy scan may be recommended depending on the timing of exposure.

Can I breastfeed while on a GLP-1?expand_more

Use during breastfeeding is not recommended. Injectable forms lack human milk data; the oral form (Rybelsus) contains an absorption enhancer detected in milk. The default conservative position is to wait until done breastfeeding to restart.

Does tirzepatide affect birth control pills?expand_more

Yes. The Zepbound and Mounjaro labels note that oral hormonal contraceptives may be less effective for 4 weeks after starting and 4 weeks after each dose escalation, because delayed gastric emptying can change pill absorption. A non-oral method or backup barrier method is generally advised during those windows.

Will my fertility improve once I stop?expand_more

Many people see menstrual cycles normalize and ovulation return — especially those with PCOS — after weight loss on a GLP-1, which can actually make conception easier than expected once the drug is stopped. Talk to your provider about timing and contraception during the washout.

Keep exploring

Browse all GLP-1 guides.